Objective: Intravenous lipid emulsion (ILE) is an emerging therapy in the field of toxicology. The purpose of this study was to report the accumulated local experience on using ILE in the management of patients suffering from poisoning by pharmaceutical agents other than local anaesthetics. Design: Case series. Setting: Local poison information centre. Methods: Ten patients were identified from the database of Hong Kong Poison Information Centre. The patients were managed in 6 Hong Kong public hospitals during a 4-year study period (July 2008-June 2012. Results: Nine of them presented with drug-induced cardiotoxicity, defined as either cardiac arrest (n=3) or hypotension refractory to other treatments (n=6). The overall survival rate is 30%. Possible adverse events from ILE included mild derangement of liver function, elevated amylase and hyperlipidaemia were observed. Conclusions: About 30% of severe poison-induced cardiotoxicity treated with ILE can survive with no major adverse effects. The use of ILE remains to be a treatment option for lipid-soluble drug induced severe toxicity not responsive to standard resuscitation measures. (Hong Kong j. emerg.med. 2015;22:100-107) ILE 4 ILE 30% ILE
Introduction
Intravenous lipid emulsion (ILE) is an emerging therapy for refractory cardiotoxicity due to lipid-soluble drugs and is currently endorsed as an antidote in cardiac arrest secondary to local-anaesthetic systemic toxicity by a number of professional anaesthesiology authorities. 1 However, only limited evidence is available on its role in managing poisoning from other agents. Animal studies demonstrated effectiveness of ILE with improved survival from drug-induced cardiotoxicity by amitriptyline, bupivacaine, clomipramine, propranolol, atenolol and verapamil. 2 Successful resuscitations with the use of ILE were reported in human cardiovascular collapse due to poisoning from antidepressant, antihypertensive, anticonvulsant, or in different combinations of drugs from the above classes with anti-psychotics, non-steroidal anti-inflammatory drug, psychostimulant and other drugs. [2] [3] [4] [5] [6] [7] Details of patients treated with ILE with favourable outcome in the literature are listed in Table 1 .
Whether ILE as part of resuscitative effort is truly beneficial in managing poisoned patient is yet uncertain given the publication bias. Wong et al had reported initial local experience on the use of ILE in hydroxychloroquine and chloroquine overdose patients with refractory shock. In both cases, the resuscitations were not successful and the patients died. 8 The purpose of this study was to report the accumulated local experience on the use of ILE in the management of toxicology patients from pharmaceutical agents other than local anaesthetics.
Subjects and methods

Study design and inclusion criteria
From July 2008-June 2012, patients receiving ILE after drug overdose were identified from the database of Hong Kong Poison Information Centre, a public advisory body and toxicology training centre which provides 24-hour telephone consultation on poison information and toxicology management advice to health care professionals in Hong Kong. A total of 10 patients managed in 6 Hong Kong public hospitals during the 4 years study period were identified and included in the case series. Relevant clinical notes and charts from each patient's hospital record were reviewed. Cardiotoxicity was defined as cardiac arrest or refractory hypotension (systolic blood pressure <90 mm Hg, despite treatment with intravenous fluid, inotrope(s), calcium, high dose insulin or sodium bicarbonate). Patients with QRS widening on electrocardiography (ECG) were also included. Survival was defined as survival to hospital discharge regardless of neurological status. Approval for reporting of anonymous patient data was obtained from the institution review board.
Data collection
Clinical notes from the relevant hospital records were reviewed. Information on overdose (time, agent and amount), indication and regime of ILE, other treatments given, subsequent changes on haemodynamics and other treatments, outcome (in terms of survival to hospital discharge, neurological status on discharge) and any documented adverse events (defined as any conditions developed after admission that require further management) were extracted.
Measurements on haemodynamics status (heart rate, systolic blood pressure, diastolic blood pressure, mean arterial blood pressure (MAP)) before ILE and the 
Results
Patient characteristics
Ten patients (9 female, 1 male) who received ILE were identified during the above study period. Their age ranged from 17-83 years old. ILE was part of the treatment for drug-induced cardiotoxicity in 9 of the patients. One case of ILE used for widening of QRS complex was also included in this series. Detailed patient characteristics are summarised in Table 2 . Multiple agents (up to four drugs) were involved in 60% of the cases. Four patients presented with single agent overdose (amitriptyline, hydroxychloroquine and aconitine roots). All were oral exposure. The drug classes included analgesic (non-opioid and opioid), tricyclic antidepressant, antihypertensive (beta blocker, calcium channel blocker, angiotensin converting enzyme inhibitor), antimalarial, antipsychotic (typical and atypical), benzodiazepine, oral hypoglycaemic agent and thyroid hormone. One case suffered from Chinese herbal medicine (CHM) poisoning. Details on the involved agents are also listed in Table 2 .
ILE regime
Only in one case, 10% Intralipid ® was used and 20% Intralipid ® were used in all other patients. All patients received the initial bolus dose(s), followed by infusion in 7 patients. Five were given multiple boluses (4 double, 1 triple) followed by infusion in 3 of them. 14 Widen QRS (>65x50-mg tablets) + 400 ml infusion intact Quetiapine over 30 minutes Citalopram Metoprolol Quinapril Aspirin 
Effect on QRS interval
Evaluation of the effectiveness of ILE treatment on widened QRS was not possible in this retrospective study due to incomplete clinical records.
Survival
Three out of the ten patients survived to hospital discharge. The overall survival rate was 30% in this case series. One of the survivors (Case 1) suffered from hypoxic brain injury with refractory seizure and a score of 14/30 on Mini Mental State Examination (MMSE) done shortly before discharge. Two of our survivors (Cases 1 and 2) suffered from cardiac arrest before administration of ILE. One of them was neurologically intact on discharge (Case 2). On the other hand, three of the mortality cases had cardiac arrest prior to ILE therapy.
Survival cases description
Case 1
A 45-year-old gentleman presented to the emergency department after overdosing unknown amount of dothiepin and propranolol. On arrival, he was in cardiac arrest with initial ECG showing pulseless electrical activity (wide complex rhythm with QRS interval up to 176 msec). Return of spontaneous circulation (ROSC) was achieved after 45 minutes of resuscitation. His haemodynamic status was unstable with one more episode of pulseless electrical activity requiring another 15-minute resuscitative effort. One bolus of 100 ml 20% Intralipid ® was given during resuscitation with ROSC achieved. Gastrointestinal (GI) decontamination with gastric lavage was done after intubation, followed by multiple doses of activated charcoal (MDAC). He was given a total of 800 ml 8.4% sodium bicarbonate, glucagon infusion, a dose of insulin at 0.5 U/kg/hour and adrenaline infusion. He was transferred to intensive care unit (ICU) for further cardiovascular support. His blood pressure and ECG normalised in the next 3 days. He was put on antiepileptic drug for refractory seizures. Computed tomogram (CT) brain was unremarkable. He was later diagnosed to have post arrest hypoxic brain injury by neurologist with MMSE score of 14/30. He was discharged on day 8.
Case 2
A 46-year-old lady presented in coma after overdosing 30 tablets of amitriptyline. Initial ECG showed typical changes associated with tricyclic antidepressant toxicity. Intubation in Accident & Emergency (A&E) department followed intravenous sodium bicarbonate bolus. She developed pulseless ventricular tachycardia that responded to defibrillation. Gastric lavage was followed by activated charcoal. Further intravenous sodium bicarbonate boluses was given (to a total of 450 ml 8.4% sodium bicarbonate) for widening of QRS interval till whole blood sodium level increased to 154 mmol/L. Unstable haemodynamics with weak pulse persisted despite sodium bicarbonate and trial of hyperventilation. Bolus of 100 ml 20% Intralipid ® followed by infusion at 0.25 ml/kg/min over 30 minutes was given at this juncture. An episode of ventricular tachycardia during ILE infusion responded to cardioversion. Adrenaline infusion was started after restoration of sinus rhythm. She was transferred to ICU after her vital signs stabilised with ILE and adrenaline. Mild liver function derangement was noted during her ICU stay. She was discharged on day 11 when her liver function test was on improving trend.
Case 3
A 45-year-old lady attended for amitriptyline (100 tablets) overdose. On arrival she was fully conscious. Her Glasgow Coma Score deteriorated to E1V1M5 while she was in A&E department. ECG showed widening of QRS interval. She was intubated and was given gastric lavage, MDAC, sodium bicarbonate, bolus (1.5 ml/kg) and infusion (0.25 ml/kg/min over 2 hours) of 20% Intralipid ® . Her haemodynamic status was stable all along. She was extubated around 8 hours later. She made an uneventful recovery and was discharged on day 3.
Adverse events
One survivor was noted to have mild liver function derangement with peak total bilirubin 43 umol/L, alkaline phosphatase 210 U/L, alanine aminotransferase 594 U/L and aspartate aminotransferase 881 U/L. Hepatitis B & C serology were negative. Liver function derangement could be related to the episode of hypotension. However, further evaluation of the causal relationship between ILE used as an antidote and the liver injury was not possible as patient defaulted further investigations.
Hyperlipidaemia was confirmed in one of our cases with the help from the Toxicology Reference Laboratory. Peak total triglycerides (TG) was 22.13 mmol/L at 1 hour after starting ILE therapy (baseline TG 1.95 mmol/L). TG returned to 2.94 mmol/L at 14 hours post-ILE administration. The hospital laboratory was not able to perform analysis of electrolytes and liver function tests on several grossly lipaemic blood samples taken during the period of elevated TG.
Discussion
We reported a case series of severe poisoning managed by ILE as part of the treatment with an overall survival rate of 30%. ILE could have a role in improving survival in our group of patients although obvious confounding factors, lack of a control group and randomisation challenged the claim of causation of outcome.
In our series, improvements in MAP and sustained return of spontaneous circulation were observed in 4 cases and 1 case respectively after the ILE therapy. However, the change in haemodynamic state could also be contributed by the other treatments and meaningful statistical analysis was not possible due to the small sample size.
Se v e r a l m e c h a n i s m s w e re p r o p o s e d f o r t h e e f f e c t i v e n e s s o f I L E i n t h e m a n a g e m e n t o f toxicology patients. The "lipid-sink" theor y postulated that ILE administration would create an expanded lipid compartment in the intravascular space. This new lipid compartment would then draw lipophilic agents out of the aqueous plasma phase, reducing their availability and thus toxicity to target organs. 9 An alternative or additional theory suggested that the administration of ILE m i g h t i m p r o v e m y o c a r d i a l f r e e f a t t y -a c i d availability, reversing the switch from lipid to glucose metabolism seen in stunned myocardium.
In addition, lipid emulsion might counteract the inhibition to oxidative phosphorylation in toxic myocardium. 10 The second theory might explain positive clinical response for drugs that perform poorly in the in vitro "link sink" model.
Concerning the safety of ILE, deep vein thrombosis (DVT), acute lung injury, ventilator-dependent respiratory failure, toe amputations suggested by Geib et al 4 were not reported in our patients. The prompt management of other predisposing factors including prolonged hypotension and ischaemia could explain this. In chronic use of Intralipid ® as calorie source, 1 in 133 adult patients was found to have unexplained rises in alkaline phosphatase, alanine transferase and aspartate transferase during treatment. 11 Unfortunately workup for the our single case of liver injury was not completed and we were unable to comment on the possible aetiology. Long-term effects of ILE could not be addressed by the current study due to the short follow up period.
Hyperlipidaemia resulting from the use of ILE could lead to inaccurate laboratory measurements on several parameters. Falsely decreased sodium levels by as much as 4.0 mmol/L could be encountered with certain analytical method. 12 This is of particular concern as sodium bicarbonate is commonly used as an antidote for widening of QRS interval and sodium level may affect the decision on further use of sodium bicarbonate. However, the magnitude of interference on analysis of electrolytes (at point-of-care test or laboratory level) by ILE is not well studied. Physicians using ILE should be aware of the potential for laboratory inaccuracies caused by lipidaemia 4 
Limitations
Apart from the small sample size, lack of control group and randomisation mentioned before, the lack of quantitative laboratory confirmation on overdose was another major limitation. Although we noted that some adverse events (digital ischaemia leading to amputation, DVT, acute lung injury, respiratory failure, etc.) were not affecting our patients, the retrospective nature of this study limited our ability to look for the presence of other adverse effects like short term memory loss. Current recommendation by the American College of Medical Toxicology 16 about the use of ILE remains to be a treatment option for lipid-soluble drug induced severe toxicity not responsive to standard resuscitation measures.
Conclusions
About 30% of severe poison-induced cardiotoxicity treated with ILE can survive with no major adverse effects. Further studies to evaluate the early use of ILE in management of such cases are needed for better understanding of the role of ILE as an antidote. The use of ILE remains to be a treatment option for lipidsoluble drug induced severe toxicity not responsive to standard resuscitation measures.
